Arix Bioscience logo

ARIX - Arix Bioscience Share Price

96.5p 0.0  0.0%

Last Trade - 17/01/20

Sector
Financials
Size
Small Cap
Market Cap £130.8m
Enterprise Value £112.4m
Revenue £1.12m
Position in Universe 913th / 1834
Bullish
Bearish
Unlock ARIX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ARIX Revenue Unlock ARIX Revenue

Net Income

ARIX Net Income Unlock ARIX Revenue

Normalised EPS

ARIX Normalised EPS Unlock ARIX Revenue

PE Ratio Range

ARIX PE Ratio Range Unlock ARIX Revenue

Dividend Yield Range

ARIX Dividend Yield Range Unlock ARIX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ARIX EPS Forecasts Unlock ARIX Revenue
Profile Summary

Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. Its principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company holds interests in BioMotiv, OptiKira LLC, Autolus, Depixus SAS, Verona Pharma plc and Artios Pharma Ltd. The Company has agreements with universities in the United Kingdom, Europe and Australia, providing direct access to new technologies. It also has access to a range of research projects from the United States academic institutions. Its subsidiaries include Arix Bioscience Holdings Limited, Arix US Inc and Arthurian Life Sciences GP Limited.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated September 15, 2015
Public Since February 17, 2017
No. of Shareholders: n/a
No. of Employees: 14
Sector Financials
Industry Holding Companies
Index
Exchange London Stock Exchange (Full)
Shares in Issue 135,551,850
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ARIX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ARIX
Upcoming Events for ARIX
Similar to ARIX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.